ADAGE CAPITAL PARTNERS GP, L.L.C. Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001165408
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2026 · 1002 positions · Total reported value $71.32B · Top-10 concentration 29.5% · Updated 2026-10-24
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
Turnover: 59.7% · 143 new · 412 cut · 129 exited
Active Share (vs S&P 500): 24.9% · vs QQQ: 54.4% — share of the book that differs from index weights (higher = more active) · ranking
In its Q2 2026 13F filing, ADAGE CAPITAL PARTNERS GP, L.L.C. disclosed 1002 equity positions with a combined reported value of $71.32B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 29.5% of reported value. HoldingsHub classifies the profile as Large / Technology Tilt / High Turnover.
The largest disclosed positions as of Q2 2026 were NVDA ($4.39B), AAPL ($3.76B), MSFT ($2.45B). By sector, the heaviest allocations are Technology 38.1%, Health Care 13.7%. Versus the prior quarter, allocation shifted toward Technology (+5.1pp) and away from Energy (-1.1pp), Consumer Discretionary (-1.4pp).
Versus the prior quarter, ADAGE CAPITAL PARTNERS GP, L.L.C. opened 143 new positions, trimmed 412 and fully exited 129, a turnover rate of 59.7% of positions. The portfolio's overlap with the prior quarter was 73% of names.
The largest new positions opened in Q2 2026 were MRVL ($222.17M), SYRE ($152.91M), D ($108.16M).
Of the 129 positions fully exited versus the prior quarter, the largest were CNTA ($354.50M), CTRA ($288.83M), SO ($114.56M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2026)
- MRVL MARVELL TECHNOLOGY INC · $222.17M
- SYRE SPYRE THERAPEUTICS INC · $152.91M
- D DOMINION ENERGY INC · $108.16M
- SYK STRYKER CORPORATION · $96.81M
- HUM HUMANA INC · $83.46M
- TEVA TEVA PHARMACEUTICAL INDS LTD · $79.98M
- ALKS ALKERMES PLC · $71.68M
- KLRA KAILERA THERAPEUTICS INC · $70.68M
Fully Exited (vs previous quarter)
- CNTA CENTESSA PHARMACEUTICALS PLC · prev qtr: $354.50M
- CTRA COTERRA EN · prev qtr: $288.83M
- SO SOUTHERN CO · prev qtr: $114.56M
- TERN TERNS PHARMACEUTICALS INC · prev qtr: $112.02M
- VOYA VOYA FINANCIAL INC · prev qtr: $102.48M
- MDGL MADRIGAL PHARMACEUTICALS INC · prev qtr: $97.02M
- HOLX HOLOGIC IN · prev qtr: $64.86M
- GTLS CHART INDS INC · prev qtr: $61.29M
Insider Transactions (Form 4)
Latest ADAGE CAPITAL PARTNERS GP, L.L.C. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Adage Capital Partners GP files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 1,002 positions worth $71.32B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 1,002 positions · $71.32B reported value (Q2 2026)
- Top 10 holdings = 29.5% of reported value
- Largest position: NVDA (NVIDIA CORPORATION) at 6.2%
- Average position size: $71.18M
Sector Tilt
- Information Technology 38.1%
- Health Care 13.7%
- Consumer Discretionary 12.3%
- (classified holdings cover 98% of value)
Quarterly Activity
- Q2 2026: 174 new, 286 added, 371 reduced, 125 exited
- 171 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
21.94M | $4.39B | 6.16% | Reduce | |
| 2 |
|
12.99M | $3.76B | 5.27% | Hold | |
| 3 |
|
6.58M | $2.45B | 3.44% | Hold | |
| 4 |
|
8.76M | $2.09B | 2.93% | Reduce | |
| 5 |
|
5.21M | $1.86B | 2.61% | Hold | |
| 6 |
|
4.20M | $1.59B | 2.22% | Add | |
| 7 |
|
4.22M | $1.49B | 2.09% | Add | |
| 8 |
|
1.03M | $1.19B | 1.67% | Reduce | |
| 9 |
|
2.06M | $1.16B | 1.63% | Hold | |
| 10 |
|
2.48M | $1.04B | 1.46% | Add | |
| 11 |
|
726.20K | $871.02M | 1.22% | Reduce | |
| 12 |
|
1.44M | $838.95M | 1.18% | Add | |
| 13 |
|
1.62M | $808.16M | 1.13% | Reduce | |
| 14 |
|
2.39M | $782.24M | 1.10% | Reduce | |
| 15 |
|
6.84M | $711.34M | 1.00% | Add | |
| 16 |
|
2.57M | $651.84M | 0.91% | Add | |
| 17 |
|
4.06M | $567.37M | 0.80% | Reduce | |
| 18 |
|
1.19M | $513.81M | 0.72% | Add | |
| 19 |
|
1.47M | $502.98M | 0.70% | Reduce | |
| 20 |
|
1.11M | $461.42M | 0.65% | Add | |
| 21 |
|
3.65M | $413.27M | 0.58% | Hold | |
| 22 |
|
567.73K | $410.47M | 0.58% | Reduce | |
| 23 |
|
3.46M | $406.72M | 0.57% | Reduce | |
| 24 |
|
1.60M | $402.26M | 0.56% | Add | |
| 25 |
|
2.88M | $393.32M | 0.55% | Add | |
| 26 |
|
367.70K | $391.57M | 0.55% | Reduce | |
| 27 |
|
395.68K | $370.14M | 0.52% | Reduce | |
| 28 |
|
6.49M | $369.95M | 0.52% | Add | |
| 29 |
|
10.35M | $366.26M | 0.51% | Reduce | |
| 30 |
|
709.61K | $364.46M | 0.51% | Reduce | |
| 31 |
|
8.45M | $349.09M | 0.49% | Add | |
| 32 |
|
1.02M | $339.97M | 0.48% | Add | |
| 33 |
|
881.66K | $329.50M | 0.46% | Reduce | |
| 34 |
|
2.12M | $310.92M | 0.44% | Reduce | |
| 35 |
|
837.26K | $295.28M | 0.41% | Reduce | |
| 36 |
|
1.72M | $285.87M | 0.40% | Reduce | |
| 37 |
|
3.45M | $280.66M | 0.39% | Reduce | |
| 38 |
|
914.84K | $276.02M | 0.39% | Add | |
| 39 |
|
234.70K | $275.74M | 0.39% | Add | |
| 40 |
|
1.22M | $274.62M | 0.39% | Add | |
| 41 |
|
1.43M | $272.08M | 0.38% | Add | |
| 42 |
|
1.85M | $270.63M | 0.38% | Reduce | |
| 43 |
|
768.30K | $262.01M | 0.37% | Reduce | |
| 44 |
|
115.10K | $261.70M | 0.37% | Add | |
| 45 |
|
2.03M | $260.86M | 0.37% | Reduce | |
| 46 |
|
3.60M | $257.21M | 0.36% | Reduce | |
| 47 |
|
898.19K | $252.58M | 0.35% | Reduce | |
| 48 |
|
1.39M | $251.46M | 0.35% | Hold | |
| 49 |
|
1.42M | $250.92M | 0.35% | Reduce | |
| 50 |
|
766.54K | $241.14M | 0.34% | Reduce | |
FAQ
What did ADAGE CAPITAL PARTNERS GP, L.L.C. buy in 2026-Q2?
In its 2026-Q2 13F filing, ADAGE CAPITAL PARTNERS GP, L.L.C. reported 1002 equity positions worth $71.32B in aggregate; its largest disclosed positions were NVDA ($4.39B), AAPL ($3.76B), MSFT ($2.45B).
How large is ADAGE CAPITAL PARTNERS GP, L.L.C.'s portfolio?
ADAGE CAPITAL PARTNERS GP, L.L.C. reported $71.32B of long equity holdings across 1002 positions as of 2026-Q2. Top-10 holdings account for 29.5% of reported value.
What is ADAGE CAPITAL PARTNERS GP, L.L.C.'s investment style?
HoldingsHub classifies the portfolio as Large / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.